β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cells

Glucagon-like peptide-1 (GLP-1) is a polypeptide hormone secreted from enteroendocrine L cells and potentiates glucose-dependent insulin secretion in pancreatic β cells. Recently the GLP-1 receptor (GLP-1 R) has been a focus for new anti-diabetic therapy with the introduction of GLP-1 analogues and DPP-IV inhibitors, and this has stimulated additional interest in the mechanisms of GLP-1 signaling. Here we identify a mechanism for GLP-1 action, showing that the scaffold protein β-arrestin-1 mediates the effects of GLP-1 to stimulate cAMP production and insulin secretion in β cells. Using a coimmunoprecipitation technique, we also found a physical association between the GLP-1 R and β-arrestin-1 in cultured INS-1 pancreatic β cells. β-Arrestin-1 knockdown broadly attenuated GLP-1 signaling, causing decreased ERK and CREB activation and IRS-2 expression as well as reduced cAMP levels and impaired insulin secretion. However, β-arrestin-1 knockdown did not affect GLP-1 R surface expression and ligand-induced GLP-1 R internalization/desensitization. Taken together, these studies indicate that β-arrestin-1 plays a role in GLP-1 signaling leading to insulin secretion, defining a previously undescribed mechanism for GLP-1 action.

[1]  J. Olefsky,et al.  Tumor Necrosis Factor Receptor-1 Can Function through a Gαq/11-β-Arrestin-1 Signaling Complex* , 2007, Journal of Biological Chemistry.

[2]  J. Lau,et al.  Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. , 2007, JAMA.

[3]  T. Schwartz,et al.  Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor β-Arrestin Recruitment and Signaling through Gα , 2007, Journal of Pharmacology and Experimental Therapeutics.

[4]  Didier Bagnol,et al.  A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. , 2007, Endocrinology.

[5]  J. Egan,et al.  Mechanisms of action of glucagon-like peptide 1 in the pancreas. , 2007, Pharmacology & therapeutics.

[6]  R. Lefkowitz,et al.  Beta-arrestins and cell signaling. , 2007, Annual review of physiology.

[7]  J. Olefsky,et al.  Regulation of Receptor Tyrosine Kinase Signaling by GRKs and β-Arrestins , 2007 .

[8]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[9]  S. Bonner-Weir,et al.  A dominant role for glucose in β cell compensation of insulin resistance , 2007 .

[10]  H. Aburatani,et al.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. , 2007, The Journal of clinical investigation.

[11]  J. Olefsky,et al.  Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins. , 2007, Annual review of physiology.

[12]  J. Olefsky,et al.  Tumor necrosis factor receptor-1 can function through a G alpha q/11-beta-arrestin-1 signaling complex. , 2007, The Journal of biological chemistry.

[13]  S. Bonner-Weir,et al.  A dominant role for glucose in beta cell compensation of insulin resistance. , 2007, The Journal of clinical investigation.

[14]  T. Schwartz,et al.  Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s). , 2007, The Journal of pharmacology and experimental therapeutics.

[15]  Lei Zhang,et al.  Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor. , 2006, Molecular endocrinology.

[16]  D. Drucker,et al.  The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes , 2006, The Lancet.

[17]  D. Drucker.  The biology of incretin hormones. , 2006, Cell metabolism.

[18]  Sunmin Park,et al.  Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic β Cell Growth and Function* , 2006, Journal of Biological Chemistry.

[19]  Lan Ma,et al.  A nuclear function of beta-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription (vol 123, pg 833, 2005) , 2006 .

[20]  Sunmin Park,et al.  Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. , 2006, The Journal of biological chemistry.

[21]  Min Zhang,et al.  A Nuclear Function of β-Arrestin1 in GPCR Signaling: Regulation of Histone Acetylation and Gene Transcription , 2005, Cell.

[22]  B. Yusta,et al.  The Glucagon-like Peptide-2 Receptor C Terminus Modulates β-Arrestin-2 Association but Is Dispensable for Ligand-induced Desensitization, Endocytosis, and G-protein-dependent Effector Activation* , 2005, Journal of Biological Chemistry.

[23]  R. Lefkowitz,et al.  Receptor-specific Ubiquitination of β-Arrestin Directs Assembly and Targeting of Seven-transmembrane Receptor Signalosomes* , 2005, Journal of Biological Chemistry.

[24]  Christopher J. Rhodes,et al.  Type 2 Diabetes-a Matter of ß-Cell Life and Death? , 2005, Science.

[25]  J. Olefsky,et al.  Insulin-induced β-Arrestin1 Ser-412 Phosphorylation Is a Mechanism for Desensitization of ERK Activation by Gαi-coupled Receptors* , 2005, Journal of Biological Chemistry.

[26]  C. Rhodes.  Type 2 diabetes-a matter of beta-cell life and death? , 2005, Science.

[27]  J. Olefsky,et al.  Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors. , 2005, The Journal of biological chemistry.

[28]  R. Lefkowitz,et al.  β-Arrestin-1 Competitively Inhibits Insulin-Induced Ubiquitination and Degradation of Insulin Receptor Substrate 1 , 2004, Molecular and Cellular Biology.

[29]  Jerrold M. Olefsky,et al.  Diabetes mellitus : a fundamental and clinical text , 2004 .

[30]  G. Holz.  Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. , 2004, Diabetes.

[31]  P. Rorsman,et al.  Insulin granule dynamics in pancreatic beta cells , 2003, Diabetologia.

[32]  John Calvin Reed,et al.  cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2 , 2003 .

[33]  R. Lefkowitz,et al.  Trafficking Patterns of β-Arrestin and G Protein-coupled Receptors Determined by the Kinetics of β-Arrestin Deubiquitination* , 2003, The Journal of Biological Chemistry.

[34]  Xueying Lin,et al.  cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. , 2003, Genes & development.

[35]  R. Lefkowitz,et al.  Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. , 2003, The Journal of biological chemistry.

[36]  J. Olefsky,et al.  Beta -Arrestin 1 down-regulation after insulin treatment is associated with supersensitization of beta 2 adrenergic receptor Galpha s signaling in 3T3-L1 adipocytes. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Olefsky,et al.  β-Arrestin 1 down-regulation after insulin treatment is associated with supersensitization of β2 adrenergic receptor Gαs signaling in 3T3-L1 adipocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. S. Worrall,et al.  Insulin Induces Heterologous Desensitization of G Protein-Coupled Receptor and Insulin-Like Growth Factor I Signaling by Downregulating β-Arrestin-1 , 2002, Molecular and Cellular Biology.

[39]  T. Shibasaki,et al.  Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion* , 2001, The Journal of Biological Chemistry.

[40]  Isao Usui,et al.  β-Arrestin-mediated Recruitment of the Src Family Kinase Yes Mediates Endothelin-1-stimulated Glucose Transport* , 2001, The Journal of Biological Chemistry.

[41]  P. Vollenweider,et al.  Insulin and Insulin-like Growth Factor I Receptors Utilize Different G Protein Signaling Components* , 2001, The Journal of Biological Chemistry.

[42]  Jie Zhou,et al.  Glucagon-Like Peptide-1 Causes Pancreatic Duodenal Homeobox-1 Protein Translocation from the Cytoplasm to the Nucleus of Pancreatic β-Cells by a Cyclic Adenosine Monophosphate/Protein Kinase A-Dependent Mechanism. , 2001, Endocrinology.

[43]  M. Doyle,et al.  Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism. , 2001, Endocrinology.

[44]  Yasuhiro Sunaga,et al.  cAMP-GEFII is a direct target of cAMP in regulated exocytosis , 2000, Nature Cell Biology.

[45]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[46]  L. Eliasson,et al.  Protein kinase A‐dependent and ‐independent stimulation of exocytosis by cAMP in mouse pancreatic B‐cells , 1997, The Journal of physiology.

[47]  B. Thorens.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Drucker,et al.  Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.